Intra-Cellular Therapies Inc (STU:23I)
€ 81.5 2 (2.52%) Market Cap: 8.63 Bil Enterprise Value: 7.68 Bil PE Ratio: 0 PB Ratio: 7.86 GF Score: 60/100

Intra-Cellular Therapies Inc Investor Webcast on Lumateperone Programs Transcript

May 04, 2021 / 06:00PM GMT
Release Date Price: €26.34 (-7.55%)
Sharon Mates
Intra-Cellular Therapies, Inc. - Co-Founder, Chairman, CEO & President

Good afternoon, everyone. I'm Dr. Sharon Mates, Chairman and CEO of Intra-Cellular Therapies. I would like to welcome you to today's webcast. Joining me today is Dr. Suresh Durgam, our Chief Medical Officer; and we are pleased to have with us Dr. Roger McIntyre, Professor of Psychiatry and Pharmacology at the University of Toronto. Dr. McIntyre is an expert on mood disorders.

First, Dr. Durgam will provide an overview of our lumateperone programs. Dr. McIntyre will follow with an overview of mood disorders and share a psychiatrist's perspective on the need for additional treatments. He will then share highlights of our lumateperone presentations from this week's American Psychiatric Association annual meeting.

Following their presentations, we will open up the conversations for questions. (Operator Instructions) Please submit your questions throughout the presentation, and we will address them at the end of the presentation.

Before we continue, we will be making forward-looking statements

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot